A ngiotensin II has multiple physiological effects on the cardiovascular, endocrine, and nervous system that are initiated by binding to G-protein-coupled specific receptors located on the plasma membrane. [1] [2] [3] Although both AT 1 and AT 2 receptor subtypes are equally distributed on cardiomyocytes, 4 -6 a number of previous studies have revealed that most of the biological response to Ang II is mediated by the AT 1 receptor subtype. [7] [8] [9] [10] [11] [12] Ang II directly stimulates heart rate, cardiac contractility, and the growth of cardiac fibroblasts and cardiomyocytes. [13] [14] [15] It also activates transcription of protooncogenes (such as c-fos, c-jun, c-myc, and Egr-1), genes encoding extracellular matrix proteins (such as collagen and fibronectin), and growth factors (such as platelet-derived growth factor and transforming growth factor-␤). 16 -18 Induction of gene expression usually requires second messengermediated activation of transcription factors. AT 1 receptors transactivate phospholipase C␤ via G protein and increase inositol trisphosphate, which in turn increases Ca 2ϩ release from endoplasmic reticulum, and diacylglycerol, which activates protein kinase C. 19 Ang II is also known to activate tyrosine kinases, such as p125 FAK , p46 SHC , and p56 SHC , and to induce serine/threonine kinases, such as mitogen-activated protein kinase (extracellular signal-regulated kinases 1 and 2). 20, 21 The AT 1 receptor also stimulates phospholipase A 2 and phospholipase D. 16 The results of these studies indicate that Ang II can induce rapid changes in gene expression that may ultimately lead to increased cell growth.
Recent studies have revealed that Ang II stimulates the JAK/STAT pathway, including JAK2, Tyk2, STAT1, and STAT2, via the AT 1 receptor in rat aortic smooth muscle cells. 22 The JAK/STAT pathway was initially discovered as a major signal transduction pathway of the cytokine superfamilies. [23] [24] [25] [26] [27] The AT 1 receptor 28, 29 is a seven-transmembrane-type G-protein-coupled receptor and is quite different from members of the cytokine receptor superfamilies. Because the configuration of the AT 1 receptor is completely different from the receptors of other cytokines, the activation mechanism or modality of the JAK/STAT pathway may be different for Ang II and other cytokines. Cytokine receptors can directly bind to JAK family kinases. When ligands bind to the cytokine receptor, JAK kinases are immediately activated by tyrosine phosphorylation. Interestingly, Bhat and colleagues 30, 31 have reported that Ang II causes delayed activation of SIF in CHO-K1 cells expressing stably transfected AT 1A receptors and have suggested that there is a special relationship between the IL-6 family of cytokines and the Ang II signaling pathway. The relation between activation of the JAK/STAT pathway and transactivation of the SIF complex by Ang II is not well understood to date.
We 32 recently reported that LIF, a member of the IL-6 family of cytokines, induced cardiac hypertrophy, activated the JAK/STAT pathway, and caused a gel mobility bandshift of SIE in cultured rat cardiomyocytes. Because Ang II is known to be a critical factor that functions as an autocrine/paracrine hypertrophic growth factor for cardiomyocytes, 33 the precise mechanism of the JAK/STAT signal transduction pathway by Ang II in cardiomyocytes should be clarified. In the present study, we report unique characteristic activation patterns of the JAK/STAT pathways and gel mobility shifts induced by Ang II, which were entirely different from those induced by LIF, in cardiomyocytes.
Materials and Methods

Cell Culture
Primary cultures of cardiomyocytes were prepared from the ventricles of 1-day-old Wistar rats (Clea Japan Inc, Tokyo, Japan) by enzymatic dissociation in 0.03% trypsin, 0.03% collagenase, and 20 g/mL DNase I. The cardiomyocytes were collected by differential adhesiveness. Cells were seeded at a density of 1ϫ10 5 cells/cm 2 on gelatincoated dishes. The cells were grown in medium 199/DMEM supplemented with 10% fetal bovine serum and penicillin (50 U/mL)/ streptomycin (50 g/mL) at 37°C in humid air with 5% CO 2 . Twelve hours after plating, bromodeoxyuridine was added to the medium at a concentration of 10 Ϫ7 mol/L for 12 hours to deplete residual nonmyocytes. The cells were then washed with the same medium and incubated for 24 hours, at which time the cardiomyocytes had formed a syncytium and were beating synchronously. They were washed 2 times with serum-free medium, incubated in serum-free medium for 24 hours, and then stimulated with Ang II. LIF was applied on cardiomyocytes at a concentration of 1000 U/mL as a control. The nonmyocyte population amounted to Ϸ5% to 10% of the total cell population, as determined by immunofluorescence staining with monoclonal anti-sarcomeric myosin antibody (MF20). In some experiments, cardiomyocytes were collected by Percoll gradients (purity, 98%). Cardiac fibroblasts were obtained from cells attached to the preplate and used after subculturing 3 to 4 times to deplete residual cardiomyocytes.
Immunoprecipitation and Western Blot Analysis
Antibodies to JAK1, JAK2, Tyk2, STAT1, and STAT3 were purchased from Santa Cruz Laboratory. Monoclonal antibody to STAT2 was purchased from Transduction Laboratories. Monoclonal antibody to phosphotyrosine (4G10) was purchased from Chemicon International Inc. Ang II was purchased from Sigma Chemical Co. Recombinant murine LIF was purchased from Genzyme.
Twenty-four hours after serum deprivation, the cardiomyocytes were stimulated with Ang II at a concentration of 10 Ϫ7 mol/L, and the cells were then washed with Dulbecco's PBS. To detect phosphotyrosine, cells were lysed in buffer containing 20 mmol/L Tris-HCl (pH 7.4), 100 mmol/L NaCl, 5 mmol/L EDTA, 1.0% Triton X-100, 10% glycerol, 0.1% SDS, 1.0% deoxycholic acid, 50 mmol/L NaF, 10 mmol/L Na 3 P 2 O 7 , 1 mmol/L Na 3 VO 4 , 1 mmol/L phenylmethylsulfonyl fluoride, 10 g/mL aprotinin, and 10 g/mL leupeptin. For protein binding analysis, the same buffer without glycerol, SDS, and deoxycholic acid was used for cell lysis. Cell lysates were precleared by incubation with protein A-or G-Sepharose beads (Sigma). Precipitating antibodies to JAK1, JAK2, Tyk2, STAT1, STAT2, or STAT3 were added to the precleared lysates and incubated for 1 hour at 4°C. Immunoprecipitates were pelleted with protein A-or G-Sepharose beads and washed 5 times with the lysis buffer. The precipitated proteins were dissolved in a sample buffer and heated at 95°C for 5 minutes. Proteins were separated on 7.5% to 10% gel by SDS-PAGE, and the fractionated proteins were electrotransferred from the gel to reinforced nitrocellulose membranes (Schleicher & Schuell) in Towbin buffer at a 400-mA direct current for 3 hours. Nonspecific binding was blocked by incubation in the blocking buffer (5% BSA, 20 mmol/L Tris-HCl [pH 7.4], and 150 mmol/L NaCl) at 4°C overnight. To detect phosphorylated tyrosine, the membranes were incubated with monoclonal antibody 4G10 for 2 hours at room temperature and then incubated with peroxidase-conjugated goat anti-mouse IgG. Similar experiments were performed with and without the AT 1 receptor-specific antagonist (CV11974, an active metabolite of TCV116). 34, 35 For the protein binding analysis, the membranes were incubated with polyclonal antibodies to the AT 1 receptor, followed by incubation with peroxidase-conjugated goat anti-rabbit IgG. Signals were visualized with an enhanced chemiluminescence detection system (ECL, Amersham) on autoradiography film (NEF-496, Du Pont).
Preparation of Nuclear Extracts
After Ang II stimulation, cultured neonatal cardiomyocytes were rinsed with PBS at 0°C and scraped into the same buffer. Nuclear extracts were prepared according to standard methods. 36 Briefly, harvested cells were resuspended in 5 vol of hypotonic buffer (10 mmol/L HEPES [pH 7.9], 10 mmol/L KCl, 1.5 mmol/L MgCl 2 , and 0.5 mmol/L dithiothreitol) supplemented with proteinase and phosphatase inhibitors (0.5 mmol/L phenylmethylsulfonyl fluoride, 10 g/mL leupeptin, 10 g/mL aprotinin, 1 mmol/L Na 3 VO 4 , and 1 mmol/L NaF), incubated for 10 minutes on ice, and sedimented. The cells were then resuspended in 2 vol of the same buffer, homogenized (Dounce homogenizer), and sedimented at 1000g for 10 minutes, and the pellet (nuclei) was collected. The pelleted nuclei were incubated for 30 minutes at 4°C in high-salt buffer (20 mmol/L HEPES [pH 7.9], 25% glycerol, 400 mmol/L NaCl, and 1 mmol/L EDTA) supplemented with proteinase and phosphatase inhibitors (see above). The nuclear extracts were dialyzed against low-salt buffer (same composition as the high-salt buffer except that the NaCl content was 50 mmol/L) overnight. The protein concentration was determined by Bradford assay.
Gel Mobility Shift Assay
Gel mobility shift assays were performed as described previously, with minor modifications. 37 Nuclear extracts (5 g) were incubated with 1 g of poly(dI-dC)-poly(dI-dC) (Pharmacia Biotech), with or without competitor oligonucleotide in 20 L of 10 mmol/L HEPES (pH 7.9), 50 mmol/L NaCl, 1 mmol/L EDTA, and 10% glycerol, for 20 minutes, at 25°C. The samples were then incubated with 1 or 2 fmol of radiolabeled probes (Ϸ5000 cpm) for 10 minutes at 25°C. The probes used in the present study were purchased from Santa Cruz Biotechnology, and their sequences have been described (SIE-DNA, 5Ј-CAGTTCCCGTCAATC-3Ј; mutant SIE-DNA, 5Ј-CAGC-CACCGTCAATC; GAS/ISRE-DNA, 5Ј-AAGTACTTTCAGTT-TCATATTACTCTA-3Ј; and mutant-GAS/ISRE-DNA, 5Ј-AAG-TACTTTCAGTGGTCTATTACTCTA-3). Binding reactions were resolved by electrophoresis on a 4% native polyacrylamide gel containing 0.5ϫ TBE buffer (25 mmol/L Tris, 25 mmol/L boric acid, and 0.5 mmol/L EDTA). Gels were run at 150 V in a cold room (4°C)
Selected Abbreviations and Acronyms
Ang II ϭ angiotensin II AT 1 ϭ Ang II type-1 GAS/ISRE ϭ interferon gamma activation site/interferon-stimulating response element IL-6 ϭ interleukin-6 ISGF ϭ interferon-stimulating gene factor LIF ϭ leukemia inhibitory factor SIE ϭ sis-inducing element SIF ϭ sis-inducing factor STAT ϭ signal transducer and activator of transcription for 2 to 3 hours in 0.5ϫ TBE buffer and dried, and x-ray film was exposed to them for 12 to 24 hours.
Results
Effect of Ang II on Phosphorylation of JAK Family Kinases
As the first step in elucidating the characteristics of Ang II-induced JAK/STAT activation in cardiomyocytes, we compared Ang II-induced and LIF-induced tyrosine phosphorylation of JAK family kinases. The results are shown in Fig  1a. LIF induced strong phosphorylation of JAK1 and JAK2 and weak phosphorylation of Tyk2 as early as 2 minutes, peaking at 5 minutes. In contrast, although tyrosine phosphorylation of both JAK2 and Tyk2 increased when the cells were stimulated with Ang II, the time course was different from that after LIF stimulation. Phosphorylation of JAK2 and Tyk2 increased by 5 minutes, peaked at 15 minutes, and continued up to 30 minutes. Phosphorylation of JAK1 was not observed. The differences between the time course of activation of JAK kinases by Ang II and LIF are summarized in Fig 1b. Phosphorylation of JAK2 was weaker and more slowly induced by Ang II than by LIF. The phosphorylation of Tyk2, on the other hand, was more intense in response to Ang II than to LIF. Similar results were obtained in five separate experiments.
Cardiomyocyte cultures obtained by preplating and bromodeoxyuridine treatment contain Ϸ10% nonmyocytes, and cardiac nonmyocytes are known to possess Ang II receptors. In order to confirm that the signals obtained in Fig 1a were produced by cardiomyocytes, we used highly purified cardiomyocytes obtained by Percoll gradient for immunoprecipitation/Western blot of the JAK kinase in some experiments. Cardiac nonmyocytes were also examined. Percoll-purified cardiomyocytes revealed JAK2 phosphorylation having the same time course as in Fig 1a. Cardiac nonmyocytes also exhibited JAK2 phosphorylation, and the time course of the phosphorylation was also similar to that of cardiomyocytes (Fig 1c) . These findings indicate that although cardiac nonmyocytes may have affected the data somewhat, the main signals in the present study were produced by cardiomyocytes.
The above findings indicate that JAK2 and Tyk2 are involved in the Ang II-induced signaling pathway in cardiomyocytes and that not only the type of JAK kinase but also the time course of activation differed for LIF compared with Ang II.
Effect of Ang II on Tyrosine Phosphorylation of STATs
In order to further investigate the differences in STAT activation between LIF and Ang II in cardiomyocytes, we analyzed tyrosine phosphorylation of the STAT family by immunoprecipitation/Western blot analysis. The results are shown in Fig 2a. All STATs, 1, 2, and 3, were almost completely unphosphorylated in unstimulated cardiomyocytes. LIF induced immediate and intense phosphorylation of STAT1 at 5 minutes and of STAT3 as early as 2 minutes, which peaked at 5 to 15 minutes and decreased at 30 minutes. LIF did not induce phosphorylation of STAT2. In contrast, STAT1 and STAT2 were phosphorylated after stimulation with Ang II, and their phosphorylation increased gradually, peaking at Ϸ15 minutes. Tyrosine phosphorylation of STAT1 was clearly more slowly activated by Ang II than by LIF. The time course of phosphorylation of STAT2 by Ang II was also slow and was almost the same as the time course for STAT1. STAT3 was not phosphorylated as of 30 minutes. Five separate Figure 1 . Effect of Ang II on phosphorylation of JAK family kinases. a, Cardiomyocytes were stimulated with Ang II (10 Ϫ7 mol/L) or LIF (1000 U/mL). Cells were lysed, immunoprecipitated with anti-JAK antibodies, electrophoresed, and blotted with anti-phosphotyrosine (anti-pY) antibody or anti-JAK antibodies. Ang II induced tyrosine phosphorylation of JAK2 and Tyk2, but not JAK1, whereas LIF strongly induced tyrosine phosphorylation of JAK1 and JAK2 but only slightly induced tyrosine phosphorylation of Tyk2. Similar results were obtained in an additional four experiments. b, Densitometric analysis of the phosphorylation of JAKs in five separate experiments is shown. Note that the time course of the phosphorylation of the JAKs was slower by Ang II than by LIF. c, Percoll-purified cardiomyocytes (purity, 98%) and cardiac nonmyocytes were stimulated with Ang II, and immunoprecipitation (IP)/Western blot analysis for JAK1 was performed. Percoll-purified cardiomyocytes underwent tyrosine phosphorylation of JAK1 as described in panel a, indicating that the signal observed in this study originated in the cardiomyocytes. 
Gel Mobility Shift Assay of GAS/ISRE and SIE in Ang II-Induced Cardiac Hypertrophy
Our previous study revealed that LIF does not affect ISGF (heterodimer of STAT1 and STAT2)-like activity in cardiomyocytes. In order to investigate whether Ang II induces ISGF-like activity in rat cardiomyocytes, nuclear extracts were prepared at various time intervals after Ang II stimulation and incubated with 32 P-labeled GAS/ISRE. The DNA-protein complexes were analyzed by gel mobility shift assay, and the results are shown in Fig 4. The DNA-protein complexes with GAS/ISRE seemed to show an immediate increase after Ang II stimulation in the early stage up to 30 minutes. Moreover, GAS/ISRE was reactivated in the late stage at 120 minutes, paralleling the delayed rephosphorylation of STAT1.
To investigate whether Ang II induces SIF (homodimer and/or heterodimer of STAT1 and STAT3)-like activity in cardiomyocytes, we performed a gel mobility shift assay for SIE and compared the results with those of LIF-induced activation of SIE (Fig 5) . LIF immediately and strongly induced SIF-like activity as early as 5 minutes. In contrast, no gel mobility shift of SIE was observed for the first 60 minutes after Ang II stimulation. Interestingly, we found that the DNA-protein complex with SIE was observed at 120 minutes after Ang II Gel mobility shift assay of GAS/ISRE. Ang II induced formation of the ISGF complex, which interacted with GAS/ISRE in the early stage up to 30 minutes. Note that Ang II also induced a gel mobility shift of both SIE and GAS/ISRE in the late stage that was maximal at 120 minutes. The results were reproduced in four separate experiments.
stimulation. This parallels the delayed phosphorylation of STAT1 and STAT3. The time course of STAT phosphorylation and the gel shift of GAS/ISRE and SIE by Ang II stimulation are summarized in Fig 6. 
Effect of AT 1 Receptor Blocker on STAT1 Phosphorylation
To determine which receptor subtypes are involved in the JAK/STAT signaling pathway in response to Ang II stimulation, we performed a similar experiment with and without the AT 1 receptor-specific antagonist CV11974. The results, shown in Fig 7, revealed that phosphorylation of STAT1 was significantly suppressed by pretreatment with CV11974. This finding indicated that Ang II-induced activation of STAT1 is mediated by the AT 1 receptor.
We examined whether delayed addition of an AT 1 blocker would affect the delayed activation of STAT3 by adding CV11974 at a concentration of 10 Ϫ5 mol/L at 30 and 60 minutes after Ang II stimulation. Delayed addition of the AT 1 blocker at both times failed to inhibit the delayed activation of STAT3 at 120 minutes, indicating that delayed Ang II stimulation does not affect STAT3 phosphorylation.
Discussion
In the present study, we demonstrated involvement of the JAK/STAT pathway in Ang II-induced signal transduction in rat cardiomyocytes. The following findings were obtained: (1) It is well known that Ang II plays a critical physiological and molecular biological role in cardiomyocytes as well as in smooth muscle cells. [38] [39] [40] Accumulating evidence indicates that Ang II mediates cardiac hypertrophy and that it exerts its effect through G-protein-coupled receptors. 19 -21 Marrero et al 22 reported that stimulation of smooth muscle cells by Ang II activates JAK2, Tyk2, STAT1, and STAT2. The JAK kinases and STAT family members activated by Ang II were found to be the same in cardiomyocytes in the early stage as in smooth muscle cells. The principle findings in the present study are that (1) not only does the JAK/STAT family differ, but the time courses of activation of the pathway by Ang II and LIF are different , and (2) Ang II induced delayed phosphorylation of STAT1 and STAT3, which parallels the delayed activation of SIE and GAS/ISRE. We 32 and others 41 have recently found that LIF, a member of the IL-6 cytokine family, causes cardiac hypertrophy and that its signal is mediated by JAK1, JAK2, STAT1, and STAT3 in cardiomyocytes. It is of interest that LIF and Ang II both activate JAK2 but that JAK1 is activated only by LIF, and Tyk2 is activated only by Ang II. STAT1 is activated by both LIF and Ang II, whereas STAT2 is activated only by Ang II, and STAT3 is activated only by LIF. Thus, Ang II activates the ISGF complex to induce transcription of GAS/ISRE, whereas LIF strongly activates the SIF complex, which interacts with SIE in the promoter. It is interesting that different growth factors that induce cardiomyocyte hypertrophy, LIF and Ang II, both use the same JAK/STAT pathway to some extent but also use a different pathway to some extent. In addition to using different JAK/ STAT pathways, it should be emphasized that the time course of activation by these two factors is different. Induction of phosphorylation in the JAK/STAT pathway in cardiomyocytes is much slower by Ang II than by LIF. We suspect that the differences in time course of phosphorylation in the JAK/STAT pathway are due to the type of receptors mediating the response. The mechanism of activation of the JAK/STAT pathway has been well investigated in cytokine receptors. [42] [43] [44] [45] [46] JAK kinases bind directly to cytokine receptors. When ligands bind to cytokine receptors, conformational changes in the receptors occur, and this induces autophosphorylation of the JAK kinases. On the other hand, the AT 1 receptor is a seven-transmembrane-type Gprotein-coupled receptor. Signal transduction of the AT 1 receptor has been extensively studied in various cell types, 47 but the mechanism of activation of the JAK/STAT pathway is still unknown. Investigation of the mechanism, eg, at sites upstream from the JAK/STAT pathway, or the protein-protein interaction between the AT 1 receptor and JAK kinases in the future may explain the different time course of these two factors.
The present study also revealed that Ang II induces late phosphorylation of STAT1 and STAT3 and stimulates late ISGF and SIF-like DNA binding activity at 120 minutes. Bhat and colleagues 30, 31 have shown that Ang II induces delayed activation of SIF-like DNA binding activity, which is maximal at 2 hours, in a cell line transfected with the AT 1A receptor (T3CHO/AT 1A ). They explored possible reasons for the delayed stimulation of SIF activity and suggested that the activation of SIF complex by Ang II is characterized by an initial inhibitory phase, followed by the induction process. The cause of the delayed activation of SIF-like DNA binding activity is still unclear, but the present study revealed that delayed addition of AT 1 blocker could not suppress the late phosphorylation of STAT3. This finding does not support the idea that Ang II causes initial inhibition of the SIF complex followed by the induction process. It suggests that (1) initial stimulation by Ang II may directly activate STAT3 in the late stage, or (2) the initial stimulus may induce a secondary factor, which in turn activates STAT3. Ang II may very well induce production of other autocrine/paracrine factors such as LIF 32 or cardiotrophin-1. 48, 49 Although cardiomyocytes and T3CHO/ AT 1A cells are completely different types of cells, our finding of delayed phosphorylation of STATs and activation of SIF complex in cardiomyocytes may reflect a phenomenon common to Ang II signaling. Further studies are needed to clarify the mechanism. Figure 7 . Effect of AT 1 receptor blocker on STAT phosphorylation. a, The effect of pretreatment with the AT 1 receptor specific antagonist CV11974 on STAT1 phosphorylation was tested. Tyrosine phosphorylation of STAT1 was significantly suppressed by CV11974. b, The effect of delayed addition of CV11974 on late phosphorylation of STAT3 was tested. CV11974 was added to the culture media at 30 and 60 minutes after Ang II stimulation. c, A summary of the densitometric analysis of the five separate experiments is shown. *PϽ.01 vs control.
